Applied DNA to Announce Q1 Fiscal 2025 Results on February 13

Applied DNA Sciences, Inc. (NASDAQ:APDN), a prominent player in PCR-based technologies, will release its first quarter fiscal 2025 financial results following the close of the market on February 13, 2025. To discuss these results, the company is organizing a conference call for shareholders and investors on the same day at 4:30 p.m. ET.

The call can be accessed domestically, internationally, and in Canada. A live webcast will also be available via the provided link. For those unable to attend, a replay of the conference call will be accessible for seven days post-event.

Applied DNA conducts its operations in the sectors of synthetic DNA manufacturing, molecular diagnostics, and industrial supply chain security services. Detailed presentations related to the results will be available on their investor relations website.